"A really great lawyer. He's who you look for in complex transactions."
Chambers USA 2024
"An excellent team leader. He has deep experience and is very efficient."
Chambers USA 2024
"Mark is an M&A whizz."
Chambers USA 2022
"Mark is spot-on with the market, deal strategization and issue-spotting."
Chambers USA 2021
"He is terrific."
Chambers USA 2021
"Excellent sense of the market, negotiation tactics and business judgment on what matters"
Chambers USA 2020
Emerging Leader
M&A Advisor 2019
40 Under 40 Honoree and recognized for representing "the best of the future of the legal profession."
Bloomberg Law 2022
Profile
Mark Bekheit, Global Vice Chair of Latham’s M&A practice, provides practical strategic advice to technology and life science companies at all stages in connection with mergers and acquisitions, minority investments, and other strategic corporate transactions.
Mark's experience includes public and private company mergers, acquisitions and divestitures, tender and exchange offers, joint ventures, and minority investments for strategic and private equity clients, as well as general corporate representation and strategic planning for both publicly-traded and privately-held companies.
Mark previously served as the lead in-house corporate lawyer of a Silicon Valley-based Fortune 500 company in its acquisitions and strategic investments in the consumer and enterprise data storage industries, which gives him first-hand experience into the relevant considerations and needs of corporations with regards to strategic transactions.
Mark is widely acknowledged for his excellence. He is recognized by Chambers USA for his M&A work in Northern California, named a 2022 40 Under 40 Honoree by Bloomberg Law, named one of the 2021 Leading Dealmakers in the US by Lawdragon 500, named a 2021 Rising Star in the Technology industry by Law360, and received the Emerging Leader award by The M&A Advisor in 2019.
Experience
A selection of Mark's experience includes representation of:
Technology
New Relic in multiple transactions, including its:
Sale to affiliates of Francisco Partners and TPG (US$6.5 billion)
Acquisitions of Co-Scale and SignifAI
Tower Semiconductor in connection with its potential acquisition by Intel Corporation (US$5.9 billion)
Five9 in connection with its potential acquisition by Zoom (US$14.7 billion)
Cloudera in connection with its acquisition by KKR and CD&R (US$5.3 billion)
Okta in connection with its acquisition of Auth0 (US$6.5 billion)
Slack in connection with its acquisition by Salesforce (US$27.7 billion)
Blend Labs in connection with its acquisition of Mr. Cooper Group’s Title 365 business (US$500 million)
Hippo in connection with its acquisition of Spinnaker Insurance Company
Facebook in connection with its acquisition of CTRL-labs
Pivotal Software in connection with its sale to VMware (US$2.7 billion)
Hortonworks in connection with its merger of equals with Cloudera (US$5.2 billion)
8x8 in connection with its acquisition of Wavecell (US$125 million)
Extreme Networks in multiple transactions, including its recent acquisition of Aerohive Networks (US$210 million)
Broadcom Ltd. (formerly Avago Technologies Limited) in connection with multiple transactions, including its:
Acquisition of Broadcom Corp. (US$37 billion)
Domestication to the United States and attempted hostile takeover of Qualcomm (US$117 billion)
Integrated Device Technology in connection with its sale to Renesas (US$6.7 billion)
Entrust Datacard in connection with its acquisition of the General Purpose HSM business of Thales
John Deere in connection with its acquisition of Blue River Technology, a company specializing in machine learning technology for agricultural applications (US$305 million)
Intuit in connection with its:
Acquisition of Demandforce (US$423.5 million)
Sale of Digital Insight Corporation (US$1.025 billion)
Sale of its commercial banking division
Sale of Intuit Websites
Sale of Medfusion
Life Sciences
CooperCompanies in its acquisitions of Generate Life Sciences (US$1.6 billion) and Cook Medical’s Reproductive Health Business (US$875 million)
Bioventus in connection with its acquisition of Misonix (US$518 million)
Amneal Pharmaceuticals in connection with its merger with Impax Laboratories (US$6.4 billion)
LivaNova in connection with its divestiture of its Cardiac Rhythm Management business to Microport (US$190 million)
Sorin SpA in connection with its merger of equals with Cyberonics (US$2.7 billion)
Industrials / Transportation
Frontier Airlines in connection with its pending merger with Spirit Airlines (US$6.6 billion)
CH2M, a design engineering services firm, in connection with its sale to Jacobs Engineering (US$2.85 billion)
T-Mobile in connection with its merger with Sprint (US$26 billion)
Virgin America in connection with its sale to Alaska Airlines (US$2.6 billion)
Latham & Watkins has been named a Law360 M&A Group of the Year in recognition of the firm’s unmatched global platform, deep industry experience, and product excellence, providing turnkey solutions to clients.
Latham & Watkins has been named a 2023 Mergers & Acquisitions Group of the Year by Law360 in recognition of the firm’s innovative work on several of the most complex and transformative deals across industry sectors.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.